Exploration of Medicine

Open Access Review

The potential anti-cancer effects of melatonin on breast cancer

Naba Kumar Das, Saptadip Samanta

Published: February 25, 2022 Explor Med. 2022;3:112–127

DOI: https://doi.org/10.37349/emed.2022.00078

Full Text PDF

40636 353 7

Open Access Original Article

Placental CD4⁺ T cells from preeclamptic patients cause autoantibodies to the angiotensin II type I receptor and hypertension in a pregnant rat model of preeclampsia

Kristin E. Reeve ... Babbette LaMarca

Published: February 25, 2022 Explor Med. 2022;3:99–111

DOI: https://doi.org/10.37349/emed.2022.00077

This article belongs to the special issue Angiotensins—A Century of Progress

Full Text PDF

4248 67 18

Open Access Review

Multi-faced roles of reactive oxygen species in anti-tumor T cell immune responses and combination immunotherapy

Tao Wang, Haiyan Xu

Published: February 25, 2022 Explor Med. 2022;3:77–98

DOI: https://doi.org/10.37349/emed.2022.00076

This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions

Full Text PDF

9503 110 6

Open Access Editorial

Elimination of hepatitis C virus infection in Europe: targeting the obstacles

Dante Romagnoli

Published: February 24, 2022 Explor Med. 2022;3:71–76

DOI: https://doi.org/10.37349/emed.2022.00075

This article belongs to the special issue Exploring Chronic Liver Disease

Full Text PDF

3456 31 1

Open Access Review

Oxidative stress in obesity and insulin resistance

Anastasija Panic ... Esma R. Isenovic

Published: February 23, 2022 Explor Med. 2022;3:58–70

DOI: https://doi.org/10.37349/emed.2022.00074

This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions

Full Text PDF

13994 303 39

Open Access Review

Reactive oxygen species in cancer progression and its role in therapeutics

Ranjeet Singh, Partha Pratim Manna

Published: February 22, 2022 Explor Med. 2022;3:43–57

DOI: https://doi.org/10.37349/emed.2022.00073

This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions

Full Text PDF

23218 490 70

Open Access Review

Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment

Priyanka Singh ... Anita Kamra Verma

Published: February 16, 2022 Explor Med. 2022;3:22–42

DOI: https://doi.org/10.37349/emed.2022.00072

This article belongs to the special issue Nanomedicine and Cancer Immunotherapy

Full Text PDF

5043 60 3

Open Access Original Article

Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)

Gürer G. Budak ... Orkun Tarkun

Published: January 18, 2022 Explor Med. 2022;3:1–21

DOI: https://doi.org/10.37349/emed.2022.00071

Full Text PDF

5879 71 1